DAKO HercepTest™
identifies Herceptin™ candidates
HercepTest™ is the first FDA-approved diagnostic system which quickly and consistently identifies the most appropriate candidates for Herceptin™ therapy.


Exciting News
from our Flow Cytometry
business unit

New Products